Want to see BON full AI Analyst Report?
BON Stock Chart & Stats
$1.70
-$0.04(-2.34%)
At close: 4:00 PM EST
$1.70
-$0.04(-2.34%)
Day’s Range― - ―
52-Week Range$1.10 - $3.40
Previous Close$1.67
Volume111.86K
Average Volume (3M)2.24M
Market Cap
$9.67M
Enterprise Value$13.67M
Total Cash (Recent Filing)$6.27M
Total Debt (Recent Filing)$12.32M
Price to Earnings (P/E)―
Beta1.66
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,086,971
10 Day Avg. Volume115,576
30 Day Avg. Volume2,242,045
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.09
Price to Sales (P/S)0.29
P/FCF Ratio-1.27
Enterprise Value/Market Cap1.41
Enterprise Value/Revenue0.73
Enterprise Value/Gross Profit3.52
Enterprise Value/Ebitda623.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market Position - Natural Health TrendPositioning in the natural health and wellness segment aligns with durable consumer demand for cleaner, ingredient-focused products. This structural market tailwind supports long-term revenue potential and product differentiation if the company maintains brand credibility and distribution presence.
Manageable Leverage And Equity BaseLow debt-to-equity and a materially larger equity base provide balance-sheet flexibility to absorb operating volatility and fund working capital or strategic investments. This cushion reduces near-term refinancing pressure and supports resilience while operating results are being rebuilt.
Historical Profitability Track RecordPrior multi-year profitability indicates the underlying business model can generate margins and positive earnings in favorable conditions. That history implies operational playbooks, distribution relationships and cost structures exist which management can leverage to restore margins when demand or cost dynamics improve.
Bears Say
Persistent Negative Free Cash FlowSustained negative free cash flow erodes liquidity and forces reliance on external funding or asset drawdowns to support operations and investment. Over months this constrains strategic optionality, raises dilution or refinancing risk, and limits the firm's ability to self-fund marketing or product initiatives needed for recovery.
Revenue Decline And Margin CompressionFalling revenue and materially compressed gross margins signal weakening pricing power or higher input costs. This combination reduces operating leverage and makes it harder to cover fixed costs, lowering sustainable profitability and making margin recovery a necessary but challenging prerequisite for durable financial improvement.
Rising Debt Amid Weak OperationsIncreasing borrowings while results turned negative raises long-term financial risk: higher interest and principal obligations tighten cash flow, amplify downside if sales remain weak, and diminish returns on equity. If operating cash flow stays thin, leverage could constrain strategic choices and recovery.
Bon Natural Life News
BON FAQ
What was Bon Natural Life’s price range in the past 12 months?
Bon Natural Life lowest stock price was $1.10 and its highest was $3.40 in the past 12 months.
What is Bon Natural Life’s market cap?
Bon Natural Life’s market cap is $9.67M.
When is Bon Natural Life’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bon Natural Life’s earnings last quarter?
Currently, no data Available
Is Bon Natural Life overvalued?
According to Wall Street analysts Bon Natural Life’s price is currently Overvalued.
Does Bon Natural Life pay dividends?
Bon Natural Life does not currently pay dividends.
What is Bon Natural Life’s EPS estimate?
Bon Natural Life’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bon Natural Life have?
Bon Natural Life has 6,086,971 shares outstanding.
What happened to Bon Natural Life’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bon Natural Life?
Currently, no hedge funds are holding shares in BON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bon Natural Life
Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts. Its operations span the People's Republic of China and international markets. The company's diverse product range includes components for personal care items, such as plant-derived aromatic compounds supplied to manufacturers of perfumes and fragrances. It also develops natural health products, featuring powdered beverages and biologically active food ingredients primarily intended for use as food additives, as well as a variety of nutritional supplements. These offerings are predominantly utilized by industrial clients in the functional food, personal care, cosmetic, and pharmaceutical sectors. Founded in 2006, Bon Natural Life Limited's main office is located in Grand Cayman, Cayman Islands.
Technical Analysis
Planet Green Holdings
―
Natural Alternatives International
―
Farmmi
―
Laird Superfood
―
Healthy Choice Wellness Corp. Class A
―